Perfect Moment Ltd. (PMNT) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 1.76%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 1.76% | Share-based compensation / revenue. Period ending 2026-06-30. $409.00K ÷ $23.28M × 100 ≈ 1.76% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 23.28M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 409.00K USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -5.45M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $23.28M | $409.00K | $-5.45M | (m) | (m) | 1.76% | (m) | (m) |
| 2026-03-31 | (m) | $23.60M | $476.00K | $-5.24M | (m) | (m) | 2.02% | (m) | (m) |
| 2025-12-31 | (m) | $22.93M | $627.00K | $-10.16M | (m) | (m) | 2.73% | (m) | (m) |
| 2025-09-30 | (m) | $22.93M | $868.00K | $-12.04M | (m) | (m) | 3.79% | (m) | (m) |
| 2025-06-30 | (m) | $22.00M | $1.10M | $-13.46M | (m) | (m) | 4.99% | (m) | (m) |
| 2025-03-31 | (m) | $21.50M | $1.33M | $-13.80M | (m) | (m) | 6.20% | (m) | (m) |
| 2024-12-31 | (m) | $24.39M | (m) | $-12.63M | $1.38M | (m) | (m) | -9.14× | Reported |
| 2024-09-30 | (m) | $24.40M | (m) | $-10.61M | $739.00K | (m) | (m) | -14.36× | Reported |
| 2024-06-30 | (m) | $24.43M | (m) | $-8.36M | $942.00K | (m) | (m) | -8.88× | Reported |
| 2024-03-31 | (m) | $24.44M | (m) | $-7.67M | $1.31M | (m) | (m) | -5.85× | Reported |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $23.44M | $3.79M | $-8.63M | $1.84M | (m) | 16.19% | -4.69× | Reported |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jerash Holdings (US), Inc. (JRSH) | United States | $0.072B | 12.47 |
| SUPERIOR GROUP OF COMPANIES, INC. (SGC) | United States | $0.201B | 25.44 |
| LEVI STRAUSS & CO (LEVI) | United States | $0.742B | 20.64 |
| CARTERS INC (CRI) | United States | $1.110B | 7.65 |
| G III APPAREL GROUP LTD /DE/ (GIII) | United States | $1.164B | 11.35 |
| COLUMBIA SPORTSWEAR CO (COLM) | United States | $2.916B | 15.36 |
| lululemon athletica inc. (LULU) | $10.735B | 8.94 |